Nucleic acid delivery vehicles
AssigneeGenzyme Corporation
InventorsCatherine R. O'Riordan, Samuel C. Wadsworth
Life of this patent
Estimating the term…
Abstract
This invention describes a nucleic acid delivery vehicle construct for transfecting and/or infecting a target cell. The construct is made of a delivery vehicle and a bifunctional complex for linking the delivery vehicle to a target cell. The bifunctional complex has a delivery vehicle-binding molecule or fragment (“delivery vehicle-binding portion”), a molecule or fragment thereof that binds to a cell surface molecule on the target cell (“cell surface molecule-binding portion”) and a linker which connects the molecules or fragments.
Claims2
A nucleic acid delivery vehicle for transfecting and/or infecting a target liver cell, said nucleic acid delivery vehicle comprising:
- an adeno-associated virus (AAV) vector comprising a transgene, said AAV vector being covalently bound to,
- a polyethylene glycol linker, said polyethylene glycol linker also being covalently bound to,
- a cell surface molecule-binding moiety selected from the group consisting of fibre knob protein, Pullulan, hepatocyte growth factor, galactose and asialofetuin.
A nucleic acid delivery vehicle for transfecting and/or infecting a target liver cell, said nucleic acid delivery vehicle comprising:
- an adenovirus vector comprising a transgene, said adenovirus vector being covalently bound to,
- a polyethylene glycol linker, said polyethylene glycol linker also being covalently bound to,
- a cell surface molecule-binding moiety selected from the group consisting of fibre knob protein, Pullulan, hepatocyte growth factor, galactose and asialofetuin.
Dependencies are inferred from the claim text.